How to Buy Theravance Biopharma Stock
Theravance Biopharma Inc
Theravance Biopharma, Inc. , a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia.
Theravance Biopharma stock last closed at $11.07, up 0.36% from the previous day, and has increased 10.04% in one year. It has overperformed other stocks in the Biotechnology industry by 0.78 percentage points. Theravance Biopharma stock is currently +48.79% from its 52-week low of $7.44, and -6.82% from its 52-week high of $11.88.
There are currently 50M TBPH shares outstanding. The market cap of TBPH is $553.51M. In the past 24 hours, 194,000 TBPH shares were traded.
How to Buy Theravance Biopharma Stock
Wondering how to invest in Theravance Biopharma stock? Here's how.
- Choose where to buy Theravance Biopharma stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you figure out where to buy Theravance Biopharma stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your investment account: Pick your method of payment and add your information.
- Research Theravance Biopharma stock: The Theravance Biopharma ticker symbol is TBPH. Is Theravance Biopharma stock a good investment? Should you buy shares of TBPH? How do TBPH's underlying business fundamentals look? Do top analysts think Theravance Biopharma is a good buy? Why has TBPH's stock price moved recently? (Hint: Our stock market research website can help you figure out if TBPH is a good stock to buy).
- Make your TBPH purchase: Decide if you will purchase TBPH shares at the current market price or use a limit order to buy TBPH shares at a given price.
- Get the latest scoop on your TBPH investment: Create a watchlist to the latest updates on your new investment in Theravance Biopharma shares.
Step 1: Choose where to buy Theravance Biopharma stock
You will need an online brokerage account in order to access the NASDAQ market and buy TBPH shares.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen your brokerage, you need to fill out some personal details so you are able to buy TBPH stock today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to start a new trading account.
- Send your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have opened your account on one of the best stock apps, you can securely and quickly fund your account:
Watch the video below if you need help depositing money into your new brokerage account.
Step 4: Research Theravance Biopharma stock
Once you have figured out the best place to buy Theravance Biopharma stock, it's important to analyze their stock before you invest, so you can wrap your head around the risk as well as the opportunity.
Theravance Biopharma Numbers
Theravance Biopharma Overview
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis.
You can view all of the due diligence checks on TBPH's stock page.
Is TBPH stock properly valued?
You can use many financial metrics, analyses, models, and charts to gauge TBPH's intrinsic value.
Using relative valuations metrics:
- TBPH may be undervalued based on its P/B ratio of 3.33x, relative to Biotechnology industry P/B ratio of 4.34x
You can access more valuation analysis on TBPH's stock here.
TBPH Financial Health Overview
Passed Health Checks:
- TBPH's operating cash flow of $32.53M allows it to safely service it's debt of $48.16M.
- Total TBPH debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the TBPH balance sheet.
- There are more short-term assets than long-term liabilities on the TBPH balance sheet.
Failed Health Checks:
- TBPH earnings of -$45.79M is not enough to cover its interest payments.
- TBPH profit margin has gone down from -72.8% to -89.4% in the past year.
- TBPH has a relatively high debt to equity ratio of 1.07.
Is it a good time to buy TBPH stock, according to analysts?
Out of 3 Wall Street analysts who track TBPH, the consensus analyst rating on Theravance Biopharma is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Theravance Biopharma stock forecast page.
TBPH Trading Indicators
TBPH Growth Metrics
Last year, TBPH revenue was $65.27M. In the last 5 year, TBPH's revenue has grown by -5.79% per year. This was slower than the Biotechnology industry average of 47.08%.
You can research TBPH's earnings and revenue performance here.
Are TBPH executives and large shareholders buying or selling the stock?
In the last year, executives and large shareholders at TBPH have bought more shares than they have sold.
Rhonda Farnum, SVP COMM MEDICAL AFFAIRS of TBPH, was the latest TBPH insider to sell. They sold $7,770.03 worth of TBPH shares on Jul 14, 2025.
Get more info about who owns TBPH stock here.
Can I get consistent income from TBPH stock?
No, Theravance Biopharma doesn't provide an income stream by paying out dividends.
TBPH Social Trading Data
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your TBPH purchase
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually fine for most investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a given price limit, use a limit order.
Click the Open button and eToro will place your order.
If you require additional help with buying stocks on eToro, click the helpful video below:
Step 6: Get the latest scoop on your TBPH investment
Now that you own some TBPH shares, you'll want to keep up with your new stock purchase.
Create a watchlist to get notified of important updates regarding your TBPH stock.
TBPH Feed
How to Buy Stock in Theravance Biopharma
To reiterate, here are the 6 steps to buy stock in Theravance Biopharma:
- Choose where to buy Theravance Biopharma stock
- Open your brokerage account
- Deposit funds into your investment account
- Research Theravance Biopharma stock
- Make your TBPH purchase
- Get the latest scoop on your TBPH investment
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Theravance Biopharma, create your watchlist below.
Other Articles You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.